
Join to view full profile
2050 Kenny RdColumbus, OH 43221
Phone+1 614-293-4969
Fax+1 614-293-6111
Dr. Singh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jaysingh Singh, MD, is a neurologist based in Columbus, OH, with subspecialties in epilepsy and neurophysiology. He completed his neurology residency at the University of Toledo and a clinical neurophysiology fellowship at the Mayo Clinic. His experience includes a role as a research assistant at The University of Toledo Medical Center and expertise in electroencephalography and epilepsy. Dr. Singh has contributed to multiple publications in reputable journals and has been involved in several clinical trials focused on epilepsy treatment. He has received multiple CMS Meaningful Use Stage 1 Certifications from Mayo Clinic and GE Healthcare.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Clinical Neurophysiology, 2016 - 2017
University of ToledoResidency, Neurology, 2012 - 2016
University of SeychellesClass of 2009
Certifications & Licensure
OH State Medical License 2012 - 2028
VA State Medical License 2016 - 2020
MN State Medical License 2016 - 2018
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2017
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2017
Clinical Trials
- Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy Start of enrollment: 2018 Aug 27
- A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy Start of enrollment: 2019 Mar 06
- A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Start of enrollment: 2020 Jan 27
Publications & Presentations
PubMed
- A guide to neuromodulation in drug-resistant epilepsy.Prachi Parikh, Irena Dolezawa, Manu Hegde, Lukas Imbach, Brian N Lundstrom
Epileptic Disorders. 2026-08-01 - 5 citationsVisual Features in Stereo-Electroencephalography to Predict Surgical Outcome: A Multicenter Study.Chifaou Abdallah, John Thomas, Olivier Aron, Tamir Avigdor, Kassem Jaber
Annals of Neurology. 2025-09-01 - 2 citationsDevelopment of a stereo-EEG based seizure matching system for clinical decision making in epilepsy surgery.John Thomas, Chifaou Abdallah, Kassem Jaber, Mays Khweileh, Olivier Aron
Journal of Neural Engineering. 2024-10-04
Abstracts/Posters
- Association of immunologically mediated peripheral neurological disorder with systemic diseaseSingh J, Pirzada N, Khuder SA, American clinical neurophysiology society, Orlando, Florida, 2/2016
- Headache prevention with cranial electrotherapy stimulation in chronic migraine. A randomized controlled trial.Tietjen GE, Thotakura S, Singh J., International headache conference, 6/2013
Grant Support
- Center for Medical and Engineering Innovation (CMEI)Pilot GrantThe Ohio State University2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









